Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Očekávání osobního přínosu subjektu z účasti v klinickém hodnocení

Olga Norková

. 2012 ; 2 (1) : 34-45.

Language Czech Country Czech Republic Media elektronický zdroj

Participation of Human Subjects in a Clinical Trial is the fundamental part of Medical Research. Human Subject's participation depends on the willingness of the potential Subjects to volunteer in such a Clinical Trial. The Subject's motivations for the Clinical Trial participation diverse based on the different motivational factors. Patient's deciding whether to participate in a Clinical trial or not is influenced mainly by the current Patient’s health status and the possibility of the available standard therapy in the treatment of a serious or a life-threatening illness. The important role in the Patient decision process takes the close relationship Physician-Patient. There is no consensus among Scientists whether the Patient’s expected therapeutic benefit using the new medicinal product is the most motivational factor for the Clinical trial participation or not. Some of the latter research has concluded that some Patients frequently overestimate the chance of benefit from particular treatment. However the Patient's expectations of the potential therapeutic benefit do not depend on the Patient's correct understandings of the Clinical Trial purpose. The Patient’s willingness to contribute to the progress of medicine and desire to help other Patients is secondary consideration for the Clinical Trial participation which is reported in the medical journals. Especially Patients suffering from a life-threatening illness report altruistic reasons however this will not exclude them to expect the potential personal benefit as well. The indirect costs reimbursement to Patients during the Clinical Trial participation might motivate many potential participants for the Clinical Trial participation. This article sought to present the most frequent Subject's Expected Benefit from the Clinical Trial participation in the context of the Patient being engaged in Medical Research. Gaining a deeper understanding of this topic might be benefited for both Researchers and Physicians.

Očekávání osobního přínosu subjektu z účasti v klinickém hodnocení [elektronický zdroj] /

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc12014880
003      
CZ-PrNML
005      
20120807165338.0
007      
cr|cn|
008      
120509s2012 xr fs 000 0cze||
009      
eAR
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Norková, Olga. $7 _AN067573 $u Fakulta humanitních studií Univerzity Karlovy
245    10
$a Očekávání osobního přínosu subjektu z účasti v klinickém hodnocení $h [elektronický zdroj] / $c Olga Norková
504    __
$a Literatura $b 18
520    9_
$a Participation of Human Subjects in a Clinical Trial is the fundamental part of Medical Research. Human Subject's participation depends on the willingness of the potential Subjects to volunteer in such a Clinical Trial. The Subject's motivations for the Clinical Trial participation diverse based on the different motivational factors. Patient's deciding whether to participate in a Clinical trial or not is influenced mainly by the current Patient’s health status and the possibility of the available standard therapy in the treatment of a serious or a life-threatening illness. The important role in the Patient decision process takes the close relationship Physician-Patient. There is no consensus among Scientists whether the Patient’s expected therapeutic benefit using the new medicinal product is the most motivational factor for the Clinical trial participation or not. Some of the latter research has concluded that some Patients frequently overestimate the chance of benefit from particular treatment. However the Patient's expectations of the potential therapeutic benefit do not depend on the Patient's correct understandings of the Clinical Trial purpose. The Patient’s willingness to contribute to the progress of medicine and desire to help other Patients is secondary consideration for the Clinical Trial participation which is reported in the medical journals. Especially Patients suffering from a life-threatening illness report altruistic reasons however this will not exclude them to expect the potential personal benefit as well. The indirect costs reimbursement to Patients during the Clinical Trial participation might motivate many potential participants for the Clinical Trial participation. This article sought to present the most frequent Subject's Expected Benefit from the Clinical Trial participation in the context of the Patient being engaged in Medical Research. Gaining a deeper understanding of this topic might be benefited for both Researchers and Physicians.
650    _2
$a lidé $7 D006801
650    _2
$a léčivé přípravky $7 D004364
650    _2
$a schvalování léčiv $7 D017277
650    _2
$a klinické zkoušky kontrolované jako téma $x metody $x normy $x využití $7 D018849
650    _2
$a experimenty na lidech $x etika $x normy $x zákonodárství a právo $7 D006805
650    _2
$a vztahy mezi výzkumníkem a subjektem $x etika $7 D035844
650    _2
$a spokojenost pacientů $7 D017060
650    _2
$a lékařská etika $7 D004992
650    _2
$a altruismus $7 D000533
650    _2
$a motivace $7 D009042
650    _2
$a odměna $7 D012201
773    0_
$t Časopis zdravotnického práva a bioetiky $x 1804-8137 $g Roč. 2, č. 1 (2012), s. 34-45 $w MED00175105
856    41
$u http://medlawjournal.ilaw.cas.cz/index.php/medlawjournal/article/view/22/28 $y plný text volně přístupný
910    __
$a ABA008 $b online $c 935 $y 2
990    __
$a 20120509123426 $b ABA008
991    __
$a 20120807165727 $b ABA008
999    __
$a ok $b bmc $g 908539 $s 771946
BAS    __
$a 3 $a 4
BMC    __
$a 2012 $b 2 $c 1 $d 34-45 $i 1804-8137 $m Časopis zdravotnického práva a bioetiky $n Čas. zdr. práva bioet. $x MED00175105
LZP    __
$a 2012-23/dkjb

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...